309
Views
18
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma

, MD PhD DSc & , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Francesco Oddone, Vincenzo Scorcia, Michele Iester, Dario Sisto, Stefano De Cilla, Paolo Bettin, Carlo Cagini, Michele Figus, Giorgio Marchini, Luca Rossetti, Gemma Rossi, Tommaso Salgarello, Gian Luca Scuderi & Giovanni Staurenghi. (2022) Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy. Clinical Ophthalmology 16, pages 1707-1719.
Read now
Gábor Holló, James Kirwan, Fernando Lopez-Lopez, Marina Zimina, Claudia Fassari & Francesco Oddone. (2022) A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy. Current Medical Research and Opinion 38:7, pages 1189-1201.
Read now
Andreas Katsanos, Ivano Riva, Banu Bozkurt, Gábor Holló, Luciano Quaranta, Francesco Oddone, Murat Irkec, Gordon N. Dutton & Anastasios G. Konstas. (2022) A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension. Expert Opinion on Drug Safety 21:4, pages 525-539.
Read now
Anastasios G. Konstas, Leopold Schmetterer, Vital P. Costa, Gábor Holló, Andreas Katsanos, Philippe Denis, Luciano Quaranta, Murat Irkec, Miguel A. Castejón, Miguel A. Teus & Alan L. Robin. (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety 19:11, pages 1445-1460.
Read now
Anastasios-Georgios Konstas, Andreas Katsanos, Georgios P. Athanasopoulos, Irini C. Voudouragkaki, Evangelia S. Panagiotou, Eirini Pagkalidou, Anna-Bettina Haidich, Dimitrios A. Giannoulis, Eleni Spathi, Theodoros Giannopoulos & L. Jay Katz. (2018) Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients. Expert Opinion on Pharmacotherapy 19:18, pages 1981-1988.
Read now
Lutz E Pillunat, Carl Erb, Auli Ropo, Friedemann Kimmich & Norbert Pfeiffer. (2017) Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study. Clinical Ophthalmology 11, pages 1051-1064.
Read now
Anastasios G. P. Konstas & Gabor Holló. (2016) Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma. Expert Opinion on Pharmacotherapy 17:9, pages 1271-1283.
Read now

Articles from other publishers (10)

Walaa Nabil Abd-AlGhafar, Fatma Ahmed Aly, Zeinab Awad Sheribah & Samar Saad. (2022) Green HPLC method with time programming for the determination of the co-formulated eye drops of tafluprost and timolol in their challengeable ratio. BMC Chemistry 16:1.
Crossref
Francesco Oddone, James Kirwan, Fernando Lopez-Lopez, Marina Zimina, Claudia Fassari, Gábor Holló, Christoph Faschinger, Enping Chen, Gábor Holló, Gabor Nemeth, Gyorgy Bator, Alexis Tsorbatzoglou, Tamas Acs, Maria Ferencz, Zoltán Sohajda, Jeno Toth, Veronika Volner, Gábor Vogt, Zsolt Biro, Andrea Facskó, János Nemes, Andras Berta, Ilona Elek, Eugene Ng, Francesco Oddone, Gemma Rossi, Luca Rossetti, Michele Vetrugno, Michele Iester, Giorgio Marchini, Vincenzo Scorcia, Giovanni Staurenghi, Carlo Cagini, Tommaso Salgarello, Paolo Bettin, Michele Figus, Gian Luca Scuderi, Stefano De Cilla, Iveta Grundmane, Nora Linavska, Lasma Volksone, Guna Laganovska, Kristine Baumane, Hans Lemij, Kjell Gunnar Gundersen, Marina Zimina, Valery Erichev, Elmira Adbulaeva, Elena Karlova, Ekaterina Zakharova, Irina Panova, Boris Malyugin, Iñaki Rodríguez-Agirretxe, Fernando Lopez-Lopez, Antonio Moreno Valladares, Javier Benitez del Castillo, Rafael Gimenez, Maria Parrilla Vallejo, Jose Javier Garcia-Medina, Alfonso Anton Lopez, Sergio Torregrosa, Jorge Loscos, Miriam Kolko, Ejaz Ansari, David Broadway, Katharine Claridge, Simon Ruben, James Kirwan, Anca Nita, Michael Smith, Areeb Moosavi, Anthony J. W. King & Matthew Kinsella. (2022) Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment. Advances in Therapy 39:8, pages 3501-3521.
Crossref
Jose J. Garcia-MedinaJavier Benitez-del-CastilloIñaki Rodríguez-AgirretxeFernando Lopez-LopezAntonio Moreno-ValladaresRafael Gimenez, Maria Parrilla Vallejo, Alfonso Anton lopez, Sergio Torregrosa & jorge loscos. (2022) Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain. Journal of Ocular Pharmacology and Therapeutics 38:3, pages 252-260.
Crossref
Ejaz Ansari, Jasna Pavicic-Astalos, Filis Ayan, Anthony J. King, Matthew Kinsella, Eugene Ng & Anca Nita. (2021) Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study. Advances in Therapy 38:6, pages 2990-3002.
Crossref
Francesco Oddone, Lucia Tanga, Péter Kóthy, Gábor Holló, Christoph Faschinger, Enping Chen, Gabor Holló, Gabor Nemeth, Gyorgy Bator, Alexis Tsorbatzoglou, Tamas Acs, Maria Ferencz, Zoltán Sohajda, Jeno Toth, Veronika Volner, Gabor Vogt, Zsolt Biro, Andrea Facskó, János Nemes, Andras Berta, Ilona Elek, Eugene Ng, Francesco Oddone, Gemma Rossi, Luca Rossetti, Michele Vetrugno, Michele Iester, Giorgio Marchini, Vincenzo Scorcia, Giovanni Staurenghi, Carlo Cagini, Tommaso Salgarello, Paolo Bettin, Michele Figus, Gian Luca Scuderi, Stefano De Cilla, Iveta Grundmane, Nora Linavska, Lasma Volksone, Guna Laganovska, Kristine Baumane, Hans Lemij, Kjell Gunnar Gundersen, Marina Zimina, Valery Erichev, Elena Karlova, Ekaterina Zakharova, Irina Panova, Boris Malyugin, Inaki Rodriguez Aguirrec, Fernando Lopez–Lopez, Antonio Moreno Valladares, Javier Benitez del Castillo, Rafael Gimenez, Maria Parrilla Vallejo, Jose Garcia Medina, Alfonso Anton Lopez, Sergio Torregrosa, Jorge Loscos, Miriam Kolko, Ejaz Ansari, David Broadway, Katharine Claridge, Simon Ruben, James Kirwan, Anca Nita, Micheal Smith, Areeb Moosavi, Anthony J. W. King & Matthew Kinsella. (2020) Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study. Advances in Therapy 37:4, pages 1436-1451.
Crossref
Elena Carnero, Jean Bragard, Elena Urrestarazu, Estefanía Rivas, Vicente Polo, José Manuel Larrosa, Vanesa Antón, Antonio Peláez & Javier Moreno-Montañés. (2020) Continuous intraocular pressure monitoring in patients with obstructive sleep apnea syndrome using a contact lens sensor. PLOS ONE 15:3, pages e0229856.
Crossref
Gábor Holló, Andreas Katsanos, Kostas G. Boboridis, Murat Irkec & Anastasios G. P. Konstas. (2017) Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. Drugs 78:1, pages 39-64.
Crossref
Prina Mehta, Ali A. Al-Kinani, Rita Haj-Ahmad, Muhammad Sohail Arshad, Ming-Wei Chang, Raid G. Alany & Zeeshan Ahmad. (2017) Electrically atomised formulations of timolol maleate for direct and on-demand ocular lens coatings. European Journal of Pharmaceutics and Biopharmaceutics 119, pages 170-184.
Crossref
Lisa V. Stottlemyer. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 491 501 .
Sheridan M. Hoy. (2015) Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension. Drugs 75:15, pages 1807-1813.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.